Home » Topics » BioWorld Science

BioWorld Science
RSS

IRF7 and PTDSS2 are therapeutic targets in HIV-1 infection

July 22, 2021

Positive phase II data for eprenetapopt plus azacitidine in TP53 mutant MDS and AML

July 22, 2021

Sorrento initiates dosing in U.K. phase II study of COVI-DROPS in outpatient setting

July 22, 2021

Positive data reported from phase Ib study of IMT-002 in T1D with HLA-DQ8 trait

July 22, 2021

Medshine Discovery patents new KHK inhibitors for NASH

July 22, 2021

FDA clears IND for Viracta's all-oral combination regimen in EBV-positive solid tumors

July 22, 2021

FDA approves IND for phase I/II study of Zofin in COVID-19 long haulers

July 22, 2021

Studies show NNRTI MK-8507 can be used with islatravir, levonorgestrel/ethinyl estradiol

July 22, 2021

New CRISPR-Cas vector designs reduce vector size and increase vector titer for HIV/AIDS treatment

July 22, 2021

All together now: Cure research plays big role at IAS 2021

July 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...